Next Article in Journal
Advancements in the Alcohol-Associated Liver Disease Model
Next Article in Special Issue
Plasma P-Tau181 for the Discrimination of Alzheimer’s Disease from Other Primary Dementing and/or Movement Disorders
Previous Article in Journal
Nanoscopic Spatial Association between Ras and Phosphatidylserine on the Cell Membrane Studied with Multicolor Super Resolution Microscopy
Previous Article in Special Issue
The Role of ApoE Serum Levels and ApoE Gene Polymorphisms in Patients with Laryngeal Squamous Cell Carcinoma
 
 
Article
Peer-Review Record

Expression of Tumor Suppressor SFRP1 Predicts Biological Behaviors and Prognosis: A Potential Target for Oral Squamous Cell Carcinoma

Biomolecules 2022, 12(8), 1034; https://doi.org/10.3390/biom12081034
by Chun Chen 1,2,3,†, Yifei Zhang 1,2,3,†, Yupeng Liu 1,2,3, Lei Hang 4,* and Jun Yang 1,2,3,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Biomolecules 2022, 12(8), 1034; https://doi.org/10.3390/biom12081034
Submission received: 24 June 2022 / Revised: 22 July 2022 / Accepted: 23 July 2022 / Published: 27 July 2022
(This article belongs to the Special Issue Biomolecules and Biomarkers in Head and Neck Medicine)

Round 1

Reviewer 1 Report

I have read with great interest the paper and I congratulate Authors. The topic is original.

In introduction section, the standard of care for OSCC should be clearly described. It should be stressed the importance of multidisciplinary management of toxicities and advances in research. Therefore, introduction would be enhanced by addition of references, such as PMID: 27933385, PMID: 25479896 to better contextualize the issue at hand in oncologic scenario.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Chen et al., have put together a nice manuscript describing the tumor suppressor potential of SFRP1 in OSCC. The authors have used TCGA OSCC and normal patient RNA seq data and performed bioinformatics analysis to see the differential expression of SFRP1 across different tumors, between normal and tumor etc. They have further shown correlation of this gene with survival and other clinicopath factors in OSCC. Overal,l the manuscript is interesting, the figures are appropriate, the topic is important and the analysis of public dataset is correctly done. However, it is lacking mechanistic insight and a causative experimental data to suggest that SFRP1 does function as a tumor suppressor. Following are my major concerns,

 

1.       Though authors have shown enrichment of Calcium pathway there is no experimental evidence in Knockdown or overexpressing cells to complement the bio-informatics findings.

2.       Western blot is required for knockdown and overexpressing cells for confirmation on the protein level.

3.       An in-vivo tumor formation assay in nude mice with either overexpressing or knockdown cells is required to show a causal relationship between SFRP1 overexpression and tumor progression/development.

4.       The English language correction is required for the manuscript.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

ok

Reviewer 2 Report

The revision has addressed my concerns. The manuscript should be accepted.

Back to TopTop